We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy (ZLd_Ld)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01501370
Recruitment Status : Withdrawn
First Posted : December 29, 2011
Last Update Posted : May 10, 2016
Information provided by (Responsible Party):
Tiziana Marangon, University of Turin, Italy

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : January 2012
  Study Completion Date : January 2012